Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Merck presents novel KSP inhibitors with utility in cancer therapy

Feb. 3, 2004

Cerus acquires mesothelin rights from Johns Hopkins University

Feb. 2, 2004

New phase I trial for RSR-13 in locally advanced NSCLC

Feb. 2, 2004

Bevacizumab inhibits tumor vascularity

Feb. 2, 2004

Exelixis scientists present new antiangiogenic ADAM-10 inhibitors

Feb. 2, 2004

Antitumor effects reported for erlotinib in metastatic head and neck cancer

Feb. 2, 2004

Xcytrin enters phase I trial in combination with Temodar for glioma

Jan. 30, 2004

Provectus prepares IND filing for Provecta

Jan. 30, 2004

Phase III Thymitaq trial cleared to continue by DSMB

Jan. 30, 2004

Merck and Jerini to develop small molecule inhibitors for cancer

Jan. 30, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 10, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026